Company intelligence / Profile preview

Munney

Denmark

Ownership: Private
Development stage: Commercial

Overview

Muna Therapeutics is a biotechnology company focused on discovering and developing therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s and Parkinson’s. The team has extensive experience in neurology drug discovery across small molecules, biologics and gene therapies from major pharma companies like Sanofi and Pfizer as well as academic backgrounds. The company appears to operate at the preclinical to early clinical stage with an emphasis on innovative approaches for CNS disorders.

Therapeutic areas: Neurology
Modalities: Small moleculeBiologicGene therapy
Industry: Biotech

Beyond the preview

Go deeper on Munney.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Munney.

Explore the full profile